Herein, silica-coated iron oxide nanoparticles modified with imidazolium-based polymeric ionic liquid (Fe 3 O 4 @SiO 2 @PIL) were fabricated as a sustainable sorbent for magnetic solid-phase extraction (MSPE) and simultaneous determination of trace antidiabetic drugs in human plasma by high-performance liquid chromatography-ultraviolet detection (HPLC-UV). The Fe 3 O 4 core was functionalized by silica (SiO 2 ) and vinyl layers where the ionic liquid 1-vinyl-3-octylimidazolium bromide (VOIM-Br) was attached through a free radical copolymerization process. In order to achieve hydrophobic magnetic nanoparticles and increase the merits of the sorbent, Br ), and T 1/2 (h) were evaluated.
Introduction
Type 2 diabetes mellitus (T2DM) and its abnormalities constitute a major metabolic disease affecting human health seriously in modern society.
1 T2DM is a heterogeneous group of disorders characterized by abnormalities in carbohydrate, protein, and lipid metabolism which can cause serious health complications including ketoacidosis, kidney failure, heart disease, stroke and metabolic syndrome (dyslipidemia, hypertension). Furthermore, for many patients with T2DM, monotherapy with an oral antidiabetic agent is not adequate and multiple drugs may be necessary to achieve glycemic control in the long term. Thus, a combination formulation which includes drugs with different and complementary mechanisms of action would potentially offer increased terms of convenience and patient compliance.
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Therapeutic drug monitoring is essential to ensure the measurement of plasma concentration for pharmacokinetic studies, bioequivalence assessment of commercially available tablet formulation, optimization of novel dosage forms and dosing regimen in combination therapy for diagnostic purposes. 5, 6 Thus, development of reliable, sensitive and rapid analytical methods is required to simultaneously determine trace amounts of antidiabetic drugs in human plasma. The structures of three antidiabetic drugs chosen for this study including metformin (MET), empagliozin (EMPA) and canagliozin (CANA) are shown in Fig. 1 .
Due to the complex matrix of plasma, sample preparation methods are oen required prior to chromatographic analysis. There are several techniques described in the literature for extraction of drugs in biological matrices such as liquid-liquid extraction (LLE), dispersive liquid-liquid microextraction (DLLME), solid phase extraction (SPE), micro-solid-phase extraction (m-SPE), solid-phase membrane micro-tip extraction (SPMMTE), etc. [7] [8] [9] [10] In this case, Saha and coauthors have described probe electrospray ionization mass spectrometry to detection of drugs from plasma samples with no or minimal sample pre-treatment. 11 Recent attempts in sample preparation are particularly focused on improving the quality of analytical results and introducing new technological expansions such as simplication, miniaturization and automation of the whole analytical method.
Due to some notable properties of iron-oxide nanoparticles including the intrinsic magnetism, low toxicity, facile preparation and high surface area-to-volume ratio, they are the most frequently used sorbents in MSPE. [12] [13] [14] [15] So far, various kinds of surface modier such as carbon nanotubes (CNTs), 16 graphene, 17 polymer 18 and cyclodextrins 19 have been utilized as exterior shell material to adjust the properties of sorbents. Core-shell structure is a common existing form for MSPE sorbents, and lately it has received great attention for different screening purposes. 20 Among these magnetic hybrid materials, modifying Fe 3 O 4 with ionic liquids (ILs) on the shell moieties has been attracting growing attention.
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Beyond the excellent physicochemical and thermal properties of the ILs, they are also recurrently recognized by their excellent solvation ability for a wide range of compounds.
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Lately, ILs have been extremely used as green extraction media in some enrichment methods for different monitoring purposes. 27 In our previous works, ILs were successfully used in micro-scale extraction methods to determine trace levels of atenolol and zinc in human plasma and food samples, respectively. 28, 29 30 However, physically adsorption of ILs on the surface of nanoparticles is truly unstable and results in poor reusability. [31] [32] [33] For this presently reason, ILs have been covalently bonded to magnetite to signicantly improve the stability and minimize ILs loss during extraction procedure.
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Literature survey revealed that polymeric bonds offer strong adhesion between the IL coating and the magnetic nanoparticles (MNPs), which prevents ionic liquids leakage. [35] [36] [37] [38] In this study, silica-coated iron oxide nanoparticles were functionalized with PIL (poly-1-vinyl-3-octylimidazolium bromide (VOIM-Br)) by a free radical copolymerization process in order to fabricate an efficient magnetic recyclable sorbent. Br À anions of PIL were synthetically changed with PF 6 À anions to increase hydrophobic character of the designed solid phase.
The new sorbent possesses the advantages of both PILs and the magnetic iron oxide. Three antidiabetic drugs involving EMPA, MET and CANA were selected as the model compounds to ascertain the feasibility of this sorbent for simultaneous extraction and preconcentration prior to quantication by HPLC-UV. To the best of our knowledge, this work is the rst report on the application of Fe 3 O 4 @SiO 2 @PIL-PF 6 for trace determination of antidiabetic drugs in human plasma. The predominant factors affecting the extraction efficiency of the analytes were evaluated in detail and optimized with one at a time approach. Ultimately, the optimum conditions were successfully used to investigate the applicability of the proposed method for the determination of antidiabetic drugs in 8 healthy fed participants and main pharmacokinetic data were achieved. Ultrapure water (Millipore, Bedford, MA, USA) was used throughout the whole experiments.
Experimental

Apparatus
Fourier transform infrared (FT-IR) spectral studies were carried out by a Vector 22 FT-IR spectrometer (Bruker, Germany) over the wavenumber range of 400-4000 cm À1 . The 1 H NMR spectra of synthesized IL were recorded with a Avance DRX-500 MHz spectrometer instrument (Bruker, Germany). X-ray diffraction (XRD) patterns were obtained with a D8 Advance X-ray diffractometer (Bruker, Germany) using Cu Ka radiation source (l ¼ 1.54059Å). Thermal gravimetric analysis (TGA) were carried out using a Pyris 1 TGA instruments (Perkin Elmer, USA) operated with a heating rate of 15 C min À1 from 25 C to 800 C under oxygen atmosphere. The size and morphology of the assynthesized nanoparticles were studied using a SIGMA VP-500 eld emission scanning electron microscope (FESEM) (Zeiss, Germany) and a Tecni F20 transmission electron microscopy (FEI, Hillsboro, OR, US). The elemental composition was characterized by an energy dispersive X-ray uorescence spectroscopy (EDXRF) (Oxford Instrument, UK) attached to the Zeiss FESEM. Magnetization measurement was performed using a vibrating sample magnetometer (VSM/AGFM Meghnatis Daghigh Kavir Co., Kashan) at room temperature by cycling the eld from À10 to 10 kOe. A Sonorex ultrasonic water bath (Misonix-S3000, USA) equipped with a digital timer and a temperature controller, a WTW Inolab pH meter (Germany), a CL centrifuge (International Equipment Co, USA) and a Heidolph heating magnetic stirrer (Schwabach, Germany) were used.
HPLC condition
The chromatographic analysis was conducted using a Waters alliance e2695, (Massachusetts, USA) system which was equipped with a Waters 2487 dual wavelength detector and C 18 TMS endcapping/reversed phase column (Luna 5 mm C 18 100 A HPLC column 250 Â 4.6 mm id, Phenomenex Co, Torrance, CA) at 40 C. The mobile phase which being used in an isocratic mode was composed of potassium dihydrogen phosphate and sodium dodecyl sulfate (0.01 M, pH 6): acetonitrile (55 : 45, v/v) and passed through column with ow rate of 1 mL min À1 (the mobile phase was ltered and degassed daily prior to use in HPLC). In the case of metformin, the retention time of this drug was too short and overlapped with solvent peak which was due to its charge. In order to retain this drug in the column and obtain better separation condition a surfactant like dodecyl sulfate was used as an ion-pairing agent. The column effluent was monitored at UV wavelength of 215 nm and the injection volume was 20.0 mL. The mobile phase was ltered by passing it through a 0.2 mm membrane lter (Millipore, Bedford, MA, USA).
Synthesis of hydrophobic Fe 3 O 4 @SiO 2 @PIL-PF 6 MNPs
The synthesis of the Fe 3 O 4 @SiO 2 @PIL-PF 6 was carried out following six well-dened steps, which are explained below: 2.4.1. Synthesis of 1-vinyl-3-octylimidazolium bromide monomers, (VOIM-Br). 1-Vinyl-3-octylimidazolium bromide monomers was synthesized by direct reaction of raw materials following the modied procedure described elsewhere. 39 1-vinylimidazole (0.05 mol) and 1-bromooctane (0.055 mol, 10% excess) was heated and maintained at 60 C for 4 h and agitated with a magnetic stirrer. Aer cooling down to room temperature, obtained brownish-yellow viscous ionic liquid monomer was extracted with toluene several times to remove the remaining starting materials. Due to the high viscosity of IL monomers, in each washing step, the solution was allowed to stand and the supernatant liquid was discarded. Finally, the resulting IL monomers was dried under vacuum. used as the protective gas in the whole experiment. Aer completion of the reaction and cooling to room temperature, the obtained black precipitate was separated from the reaction media using an external magnetic eld. Next, it was washed with water and ethanol in order to remove the unreacted chemicals. Finally, the resulting material was dried in vacuum. 2.4.3. Synthesis of silica-coated iron oxide magnetic nanoparticles, Fe 3 O 4 @SiO 2 MNPs. For this purpose, previously reported biphase method was applied with some modica-tions. 40 The silica coated core-shell magnetic nanoparticles (Fe 3 O 4 @SiO 2 MNPs) were prepared by an ultrasonic premixing of the black precipitate of Fe 3 O 4 (2.0 g) with deionized water (400.0 mL) for approximately 10 min at room temperature. Then, the pH value of the solution was adjusted to 9-11 using aqueous NH 3 (25% (w/w)) and aerwards 16.0 mL TEOS were slowly added. The resulting solution were reuxed at 90 C under nitrogen protection, during continuous stirring for 2 h. Aer cooling to ambient temperature the black precipitate product (Fe 3 O 4 @SiO 2 ) was collected by magnetic separation and rinsed with water and ethanol thoroughly before being dried under vacuum. In this step, according to our scientic experience, the chemical stability of 2.4.5. Synthesis of silica-coated iron oxide magnetic nanoparticles functionalized with polymeric ionic liquid, Fe 3 -O 4 @SiO 2 @PIL-Br MNPs. PIL was immobilized on the magnetic nanoparticle surface by the free radical copolymerization using AIBN as an initiator through a simple reux. Freshly prepared Fe 3 O 4 @SiO 2 @VTES nanoparticles (0.5 g) were suspended in 2-propanol and the resulted suspension was sonicated for 10 min in ultrasonic bath to gain a homogeneous solution. It was followed by addition of AIBN and 1-vinyl-3-octylimidazolium bromide monomers through stirred continuously for 4 h while nitrogen gas was purged. The resultant product was permitted to cool, isolated by magnet, washed sequentially with distilled water and then dried in vacuum.
2. ) were prepared separately by dissolving proper amounts of each drug in HPLC grade methanol. These solutions were substituted every week with new ones to prevent decomposition of the drugs. The working standard solutions were daily prepared by appropriate stepwise dilution of the stock standard solutions with deionized water to the desired concentration. Standards for plotting calibration curve were provided by spiking the working solutions into human plasma. Quality control (QC) samples of each drug at concentration levels of 25.0, 500.0 and 1000.0 ng mL À1 were prepared for evaluating the accuracy and precision of the method. All the solutions were stored in a dark brown glass vials under refrigeration at À18 C and brought to ambient temperature just prior to use.
Plasma sample preparation
Every frozen human plasma were rstly thawed at room temperature and placed into a sample glass tube. Preparation of plasma before MSPE method was based on protein precipitation with aid of acetonitrile. In this regard, the plasma (1.9 mL) was fortied with 100.0 mL of required concentrations of analytes followed by mixing with 2.0 mL ACN. The obtained solution was vortexed for 1 min and centrifuged for 5 min at 3500 rpm. Then, ACN content of the clear supernatant was evaporated under nitrogen stream and the remaining sample was transferred into 4.0 mL buffer solution at pH 4.0. Sample volume aer evaporation under nitrogen stream was about 2 mL and total sample volume aer transferring to 4 mL buffer solution was about 6 mL. 5.0 mL of the deproteinized samples containing target drugs were subjected to the extraction procedure for subsequent analysis.
Recommended MSPE procedure
The experimental MSPE setup is shown in Fig. 2 . Initially, 5.0 mL of the deproteinized human plasma (initial volume of spiked plasma sample 2.0 mL) was placed into a glass tube and 10.0 mg of magnetic Fe 3 O 4 @SiO 2 @PIL was added to the sample. The mixture was sonicated for 4 min to totally disperse the magnetic sorbent through the matrix and complete the extraction of target drugs at room temperature. Analyte-loaded sorbent was collected from the sample solution by exposing the glass tube to a powerful neodymium-iron-boron (Nd-Fe-B) magnet (5 Â 5 Â 4 cm, 0.8 tesla), and the upper phase was poured out. Later, the adsorbed analytes were eluted by 1.0 mL of acetonitrile (0.5 mL every time and washed two times) to desorb the analytes. Elution process was completed during 2 min in the ultrasonic bath. The magnet was used again to separate the sorbent and then the total volume of eluted solution was collected and evaporated to dryness under stream of the nitrogen. The dry residue was re-dissolved in 100.0 mL of mobile phase and stirred for 1 min. Finally, 20.0 mL of this solution was injected into the HPLC-UV system for analysis. 
Results and discussion
Transmission electron microscopy (TEM).
As presented in Fig. 3A , the core-shell structure of sorbent can be clearly distinguished. In fact, the Fe 3 O 4 cores are surrounded by a dense layer of SiO 2 @PIL-PF 6 shell with the mean thickness of approximately 10 nm (the Fe 3 O 4 core is black while the SiO 2 @PIL-PF 6 shell is grey). Furthermore, this image depict that the particles are rather monodisperse and have uniform spherical shape with homogeneous distribution. They have average particle size of 15-20 nm and no free nanoparticles can be found.
3.1.3. Fourier transform infrared spectroscopy (FT-IR). Fig. 3B(a-d) ( Fig. 3B(b) ), the absorption band of Fe 3 O 4 @SiO 2 @VTES (Fig. 3B(c) ) at 3200-3675 cm À1 was reduced which revealing that most hydroxyl groups were reacted with ethoxy groups of VTES and also implying to successful coating with VTES. As it is clear in Fig. 3B(d Fig. S3(a and b) † it can be concluded that: (1) 6 ) were recorded and exhibited in Fig. 4(a-c) . At rst glance, the round surface of MNPs is obvious which provides superior active surfaces area for the adsorption of the target drugs during MSPE. Rougher structure of Fe 3 O 4 @-SiO 2 @PIL-PF 6 (c) than Fe 3 O 4 (a) could be attributed to successful surface coating. Also it can be evidently concluded from FESEM images, the size of magnetic nanoparticles aer anchoring the PIL onto the silica-coated iron oxide is not signicantly changed and is still in dimension of nanometers. This exploration reveals that Fe 3 O 4 @SiO 2 @PIL-PF 6 MNPs were coated by a thin layer of the polymeric ionic liquid providing abundant various active reaction sites for graing.
3.1.8. Energy dispersive X-ray uorescence spectroscopy (EDXRF). The elemental composition of the nano-sized sorbent was also determined using an energy dispersive X-ray uores-cence spectroscopy (EDXRF) system coupled with FESEM. The EDXRF spectra are shown in Fig. S4(a-c) . † EDXRF spectrum of Fe 3 O 4 clearly species the presence of iron (Fe) and oxygen (O) elements (Fig. S4a †) . Meanwhile, following the modication process the results unambiguously corroborates the existence of iron (Fe), oxygen (O), silicon (Si) in Fe 3 O 4 @SiO 2 (Fig. S4b †) , and iron (Fe), oxygen (O), silicon (Si), carbon (C), nitrogen (N), phosphorus (P) and uorine (F) in Fe 3 O 4 @SiO 2 @PIL-PF 6 (Fig. S4c †) . In order to access elemental distribution of the sorbent, elemental mapping was studied (Fig. S5 †) . practical parameter, which affects the extraction efficiency and subsequent measurements. 41 The required amount of MNPs for the complete separation and recovery of antidiabetic drugs (concentration level of 250 ng mL À1 ) was studied in the range of 2-18 mg. As it can be seen in Fig. 5A , maximum extraction efficiency was achieved at 10.0 mg of MNPs. These satisfactory results reveal that quantitative recoveries can be obtained with low amounts of this nano-sized sorbent in comparison with ordinary micro-sized sorbents in SPE, which is due to the advantage of high surface area in NPs. 42 Metformin has no aromatic ring whereas empagliozin, and canagliozin have aromatic rings and more resonance systems which this fact affects on the absorbance coefficient in UV region, the kind and efficiency of interactions between sorbent and drugs (for example p-p interactions) and subsequent extraction effectiveness. However, by increasing the dosage from 10.0 mg the extraction efficiency of the target analytes decreases slightly. This might be attributed to the fact that all magnetic nanoparticles may not be separated effectively and were suspended in the solution at the same duration. Furthermore, the accessible surface of the sorbent for sorbent-drug interactions reduces owing to the aggregation of the adsorbent in higher amounts which nally leads to a decrease in extraction efficiency. Hence, 10.0 mg of sorbent was selected as the optimum and applied for the rest of the experiments.
3.2.2. Effect of sample pH. The pH of sample media is one of the most important factors controlling the adsorption performance of the analytes on Fe 3 O 4 @SiO 2 @PIL MNPs. 43 In order to achieve the best extraction condition, the impact of sample pH was evaluated within the range of 2.0-12.0 using 0.01 M HCl and NaOH. The results in Fig. 5B indicated that maximum adsorption performance and reproducible data occurred at pH 4.0. Moreover, MNPs exhibit no adsorption improvement at pH values above 4. MET has acid dissociation constant values (pK a ) of 2.8 and 11.5 and, thus at pH values around 7 like physiological media it exists as the hydrophilic cationic species. 44 But by changing the pH solution the molar ratio of uncharged form to charged form of metformin alters which affects on its solubility in water and hydrophobic property. Recently, Desai and co-workers have reported that metformin hydrochloride tablets dissolved more slowly in pH 1.2 and 4.5 as compared with pH 6.8. 45 They have reported that at pH range of 1.2 to 4.5 cationic metformin forms an insoluble crystalline salt through an interaction with anionic compounds (as an ion-paring agent) like surfactants, but this phenomenon does not take place at pH 6.8. So, at pH around 7 partition coefficient of MET in biphasic system of n-octanol and water is low which is due to the positive charge of MET. But in real samples like human plasma or tablets due to the presence of many anionic compounds, the conditions may be different as Desai and co-workers reported. These results reported in literature are in agreement with the data obtained in the recent study and it seems at pH 4.0 insoluble crystalline of MET (as hydrophobic species) interacts with hydrophobic sorbent leading to the desirable adsorption of the drug. Also, CANA and EMPA with alcoholic groups are weak acids and therefore, at low pH values uncharged forms of analytes are predominate and thus stronger hydrophobic-hydrophobic interactions take place resulting better extraction performance. Hence, pH 4.0 was selected as the optimum for the following studies.
3.2.3. Effect of extraction time. Adequate ultrasound time assurances the complete dispersion of the sorbent through the sample media and provides better mass transfer and higher recovery values. 46 The inuence of this variable was investigated in the range of 0-10 min. As it can be seen in Fig. 5C(a) duration time of 4 min was suitable to reach satisfactory extraction equilibrium. When the extraction time was more than 4 min, recoveries of the analytes decreased slightly. This observed drop in signals probably indicates that with an increase in the extraction time some parts of the analytes return to the solution and resulting a minor decrease in recovery. Accordingly, an extraction time of 4 min was selected for the rest of the work.
3.2.4. Effect of desorption condition. Three organic solvents involving methanol, acetonitrile and acetone were selected for eluting the analytes. The analytical signals obtained for the target drugs indicated that the desorption ability of ACN was much stronger than the other organic media. So, ACN was chosen as the optimum desorption agent in all experiments. To investigate the effect of eluent volume on the desorption efficiency, volumes ranging from 0.5-4.0 mL were tested. The experimental results revealed that with increasing the amount of ACN up to 1.0 mL extraction efficiency increased. This was due to the good dispersion of the sorbent in this medium, which provided more interaction between the sorbent and drugs. Further increase in the solvent volume has no signicant consequence on the extraction efficiency. Hence, 1.0 mL of desorption solvent was utilized as the optimum volume for the next studies to ensure efficient elution of the analytes. However, using 0.5 mL in two times washing offered more steady analytical responses. The inuence of desorption time on the extraction performance was studied from 0.5 to 5 min and the results indicated that 2 min was sufficient enough to elute and desorb the drugs from the MNPs.
3.2.5. Effect of ionic strength. Due to salting out effect, addition a salt like NaCl causes a reasonable increase in ionic strength of sample media resulting an improvement in extraction performance. 47 The inuence of ionic strength on the extraction efficiency of antidiabetic drugs was also explored by adding various amounts of sodium chloride over the concentration range of 0-10% w/v in the sample solution. According to the results provided in Fig. 5D , by raising the salt concentration a notable reduction in signals was observed. It was due to the fact that the aqueous solution viscosity would increase with the addition of salt, which results in difficult mass transfer and also can cause abatement the interaction of analytes with sorbent surface and ultimately reduces the extraction efficiency. Consequently, absence of salt was more suitable for recommended MSPE procedure and all the experiments were accomplished without salt addition.
Reusability of the sorbent
The magnetic nanoscale sorbent can disperse in the plasma medium, and in the presence of magnetic eld it can be separated easily. Aer the extraction of analytes, the sorbent could be conveniently regenerated by rinsing the MNPs sequentially with 2.0 mL of ACN and 2.0 mL double-distilled water during sonication time of 4 min. Aer drying, the sorbent was applied for subsequent MSPE. The extraction recovery of analytes decreased approximately 10% aer 14 cycles of MSPE procedure which indicated a slight loss of the sorption capacity.
Method validation
3.4.1. Analytical performance. To assess the practicability of the developed protocol, the gures of merits including linear dynamic range (LDR), correlation coefficient (r 2 ), limit of detection (LOD), limit of quantication (LOQ) and extraction recovery (ER) for MET, CANA and EMPA were evaluated under the optimized experimental conditions. Calibration curves were plotted using different spiked human plasma with three independent measurements for each point. The enrichment factor (EF) was dened from the ratio of slope of preconcentrated samples to those obtained without preconcentration method. The extraction recovery (ER) was calculated by the following equation: : correlation coefficient; LOD: limit of detection; LOQ: limit of quantication; EF: enrichment factor; ER: extraction recovery (250.0 ng mL À1 of each drug was used).
The analytical performance data are summarized in Table 1 . The calibration curves were linear over the concentration ranges of 5.0-1200.0 ng mL À1 for EMPA, 20.0-1800.0 ng mL À1 for MET and 5.0-1000.0 ng mL À1 for CANA while correlation coefficient varied from 0.993 to 0.997. The LODs based on S/N ¼ 3 were 1.3 ng mL À1 , 6.0 ng mL À1 and 0.8 ng mL À1 for EMPA, MET and CANA, respectively. The chromatograms for blank and spiked human plasma are exhibited in Fig. 6 and indicated that there was no remarkable interference in the whole analytical protocol.
Precision and accuracy.
The intra-day and inter-day precisions and accuracy of the method were evaluated by assaying spiked samples at QC levels (25.0, 500.0 and 1000.0 ng mL À1 ) in the same day and in three consecutive days, respectively. The relative standard deviations (RSDs) of the intra-day and inter-day assays and accuracy values are summarized in Table 2 . The RSDs of the intra-daily tests are less than 7.5% and the RSDs of inter-daily tests are less than 8.5%. These results prove the reasonable accuracy and precision of the method for monitoring of antidiabetic drugs in biological matrix. 
Application of the method to pharmacokinetic assessment
In order to evaluate the capability and validity of the proposed method, it was applied for determination of EMPA, MET and CANA in human plasma and main pharmacokinetic data were calculated. Eight healthy fed male volunteers within the age range of 28-42 years old were enrolled in these studies. Oral administration of a xed-dose combination Invokamet tablet (50 mg CANA/500 mg MET) was performed to four volunteers and the blood samples were collected at 0, 1, 2, 3, 4, 5, 6, 8, 10, 12 and 24 h aer drug administration. The plasma samples were immediately transferred into a clean polypropylene tube and stored at À18 C until being used. All assessments were approved by "The Committee For Research Ethics" of Department of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences. In the next experiments, a single oral dose administration of Jardiance tablet (25 mg EMPA) was performed to four volunteers and the blood samples were collected and treated as the previous experiments. Each real sample was extracted at optimal conditions by the proposed procedure and the mean plasma concentration-time curve was obtained. The main pharmacokinetic parameters including T max , C max , AUC 0-t , AUC 0-N , and T 1/2 are summarized in Table 3 . These data demonstrate the exibility of the method in multipurpose analytical applications and its validity for trace drug monitoring in complex biological matrix.
Comparison with other methods
Comparison of the proposed method with different existing methods for extraction and determination of antidiabetic drugs is provided in Table 4 . It was revealed that along with its simplicity, present combination benets from some advantages such as low LODs, wide linearity ranges, high sensitivities and reasonable recoveries of target analytes with an important emphasis on the reusability of the sorbent which is comparable with existing techniques. These advantages conrm applicability of the present extraction/preconcentration procedure for trace monitoring of antidiabetic drugs in complex plasma matrices.
Conclusion
The aim of present study was to develop and validate a reliable MSPE method based on PIL-coated Fe 3 O 4 @SiO 2 nanoparticles for simultaneous extraction, preconcentration and determination of antidiabetic drugs from human plasma. Chemical immobilization of PIL on the surface of Fe 3 O 4 @SiO 2 core-shell through polymeric bonds offers strong adhesion between the IL and MPNs which prevents ionic liquids leakage. Furthermore, the later modication merges the interesting advantages of MNPs with individual characteristics of ILs resulting signicant improvements in stability, reusability, mass transfer capacity and diffusion routes of the nanoscale sorbent. The successful pharmacokinetic study with low dose administration of antidiabetic drugs demonstrated that the current enrichment procedure in combination with HPLC-UV is a valid means for screening purposes. According to these criteria, the validated method has notable potential for further toxicodynamic and bioequivalence studies.
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